Neuroimmunology News

Nov 20, 2020
Gut immune cells may help send multiple sclerosis into remission
Gut immune cells travel to the brain during multiple sclerosis flare-ups and seem to be playing a protective role, helping drive symptoms back into remission.
Oct 08, 2020
Simple sugar possible therapy for repairing myelin in multiple sclerosis
N-acetylglucosamine activates myelin stem cells to promote primary myelination and myelin repair.
Aug 25, 2020
Childhood obesity could increase the risk of multiple sclerosis
Childhood and adolescent obesity is projected to contribute up to 14% of overall risk of multiple sclerosis in 2035.
Aug 13, 2020
Multiple sclerosis drug may be used to inhibit HIV infection and reduce latent reservoir
Fingolimod, used to treat multiple sclerosis flare-ups, may inhibit HIV replication and consequently reduce the latent reservoir.
Aug 06, 2020
Drug prevents multiple sclerosis relapses in phase 3 trial
Trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis.
Jun 17, 2020
Evidence lacking for drug treatment of multiple sclerosis-related cognitive impairment
Systematic review of available drugs for treating multiple sclerosis fails to identify interventions effective for treating cognitive symptoms.
Jun 15, 2020
Case series: Teriflunomide therapy in COVID-19 patients with multiple sclerosis
Case series addresses concerns about whether immunotherapies for multiple sclerosis could influence risk for infection or lead to an unfavorable outcome.
Apr 16, 2020
Mental health and brain research must be a higher priority in global COVID-19 response
Paper highlights need to tackle harmful impacts of COVID-19 pandemic on mental health and potentially the brain and calls for more research on these areas.
Mar 27, 2020
FDA approves ozanimod for multiple sclerosis
Ozanimod is the latest in a series of novel medicines to originate from the laboratories of Scripps Research.
Mar 11, 2020
Diet has an impact on the multiple sclerosis disease course
Study shows the application of propionic acid in addition to multiple sclerosis medication reduces the relapse rate and the risk of disability progression in the long term.
Next ▶